Is Aimei Health Technology Co., Ltd a good investment? Aimei Health Technology Co., Ltd (AFJK) is currently trading at 12.39 USD.
In terms of valuation, the stock trades at a P/E ratio of 177.00. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Aimei Health Technology Co., Ltd is expected to release its next earnings report on March 27, 2026.
No, it does not currently pay a dividend.
Aimei Health Technology Co., Ltd is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be March 27, 2026. The company currently has a trailing EPS of 0.07.
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Community Discussion